
Last update at 2026-06-17T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -14.77021M | -14.86236M | -13.76975M | -14.00669M | -3.88866M |
| Minority interest | - | - | - | - | - |
| Net income | -14.77101M | -14.86316M | -13.77055M | -14.03717M | -3.90480M |
| Selling general administrative | 6.34M | 5.40M | 5.58M | 8.54M | 2.36M |
| Selling and marketing expenses | - | - | 0.06M | - | - |
| Gross profit | 0.10M | -0.03187M | -0.25373M | 1.41M | 0.41M |
| Reconciled depreciation | 4.78M | 4.80M | 4.88M | 4.83M | 2.04M |
| Ebit | -14.05831M | -14.24589M | -13.64415M | -13.97621M | -3.86743M |
| Ebitda | -9.27816M | -9.44418M | -8.77310M | -9.11973M | -1.82553M |
| Depreciation and amortization | 4.78M | 4.80M | 4.87M | 4.86M | 2.04M |
| Non operating income net other | - | - | - | - | - |
| Operating income | -13.99041M | -13.84120M | -13.20640M | -13.97621M | -3.86743M |
| Other operating expenses | 14.11M | 13.86M | 13.33M | 17.50M | 4.46M |
| Interest expense | 0.71M | 0.62M | 0.14M | 0.05M | 0.02M |
| Tax provision | 0.00080M | 0.00080M | 0.00080M | - | - |
| Interest income | - | - | - | - | - |
| Net interest income | -0.71190M | -0.61647M | -0.10208M | -0.05353M | -0.01869M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 0.00080M | 0.00080M | 0.00080M | 0.03M | 0.02M |
| Total revenue | 0.12M | 0.02M | 0.12M | 3.52M | 0.59M |
| Total operating expenses | 14.09M | 13.81M | 12.95M | 15.38M | 4.28M |
| Cost of revenue | 0.02M | 0.05M | 0.38M | 2.11M | 0.18M |
| Total other income expense net | -0.77980M | -1.02116M | -0.56335M | -0.03048M | -0.02124M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -14.77101M | -14.86316M | -9.97706M | -14.00669M | -3.88866M |
| Net income applicable to common shares | - | - | - | - | -3.88866M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 20.87M | 28.82M | 31.84M | 37.11M | 40.82M |
| Intangible assets | 19.23M | 23.75M | 28.28M | 32.81M | 37.33M |
| Earning assets | - | - | - | - | - |
| Other current assets | 0.43M | 0.30M | 0.42M | 0.20M | 0.47M |
| Total liab | 13.31M | 13.30M | 7.39M | 2.48M | 30.63M |
| Total stockholder equity | 7.56M | 15.52M | 24.45M | 34.63M | 10.20M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 0.73M | 0.85M | 1.18M | 1.21M | 27.00M |
| Common stock | 0.07M | 0.15M | 0.05M | 0.20M | 1.44M |
| Capital stock | 0.07M | 0.15M | 0.05M | 0.20M | 1.44M |
| Retained earnings | -67.52033M | -52.74932M | -37.88616M | -24.11561M | -10.10892M |
| Other liab | - | - | - | - | - |
| Good will | - | - | - | - | - |
| Other assets | - | - | - | - | 0.09M |
| Cash | 0.42M | 3.89M | 1.89M | 1.85M | 1.75M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 1.08M | 3.95M | 1.34M | 2.47M | 30.59M |
| Current deferred revenue | 0.35M | 0.11M | 0.11M | - | - |
| Net debt | 10.58M | 8.11M | 4.08M | -0.58474M | 1.87M |
| Short term debt | - | 3.00M | 0.04M | 1.26M | 3.59M |
| Short long term debt | - | 3.00M | 0.04M | 1.26M | 29.59M |
| Short long term debt total | 11.00M | 12.00M | 5.96M | 1.27M | 3.62M |
| Other stockholder equity | 75.26M | 68.52M | 62.56M | 58.75M | 18.86M |
| Property plant equipment | - | - | - | - | 1.19M |
| Total current assets | 1.14M | 4.34M | 2.47M | 2.85M | 2.22M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | - | - | -27.13208M |
| Short term investments | - | - | - | - | - |
| Net receivables | 0.00002M | 0.00006M | 0.00046M | 0.20M | - |
| Long term debt | 11.00M | 9.00M | 5.92M | - | - |
| Inventory | 0.30M | 0.14M | 0.17M | 0.60M | - |
| Accounts payable | - | - | - | - | 1.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -0.24929M | -0.40953M | -0.26885M | -0.20165M | 0.00580M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 0.16M | 0.17M | 0.21M | 0.08M | 0.09M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 19.73M | 24.48M | 29.37M | 34.26M | 38.60M |
| Capital lease obligations | - | - | - | 0.00810M | 0.03M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -0.12529M | -0.08263M | -0.63018M | -0.18052M |
| Change to liabilities | - | - | - | - | 0.85M |
| Total cashflows from investing activities | -0.00222M | -0.12529M | -0.10153M | - | -0.18052M |
| Net borrowings | -1.00000M | 8.12M | 5.31M | - | 3.09M |
| Total cash from financing activities | 1.01M | 8.03M | 4.92M | 3.83M | 3.15M |
| Change to operating activities | - | - | - | - | -0.41505M |
| Net income | -14.77101M | -14.86316M | -13.77055M | -14.00669M | -3.88866M |
| Change in cash | -3.47557M | 2.01M | 0.03M | 0.10M | 1.73M |
| Begin period cash flow | 3.89M | 1.89M | 1.85M | 1.75M | 0.02M |
| End period cash flow | 0.42M | 3.89M | 1.89M | 1.85M | 1.75M |
| Total cash from operating activities | -4.61470M | -5.80827M | -4.69467M | -3.02118M | -1.24998M |
| Issuance of capital stock | 2.01M | 0.00000M | 0.00000M | - | - |
| Depreciation | 4.78M | 4.80M | 4.85M | 4.83M | 2.04M |
| Other cashflows from investing activities | 0.03M | -0.10396M | -0.00854M | - | -0.03673M |
| Dividends paid | - | - | 0.05M | - | - |
| Change to inventory | -0.15181M | 0.02M | 0.22M | -0.59522M | 0.00302M |
| Change to account receivables | 0.00003M | 0.00040M | 0.20M | -0.20155M | -0.41505M |
| Sale purchase of stock | -0.00026M | 0.00000M | -0.00030M | - | - |
| Other cashflows from financing activities | 1.01M | -0.09750M | -0.39000M | -42.01980M | -42.82922M |
| Change to netincome | - | - | - | - | 0.15M |
| Capital expenditures | 0.03M | 0.02M | 0.09M | 0.63M | 0.14M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | 0.73M | 0.04M | 0.19M | -0.26980M | 0.44M |
| Stock based compensation | 1.73M | 3.54M | 1.11M | 6.42M | 0.15M |
| Other non cash items | 2.92M | 0.67M | 2.90M | - | 0.00222M |
| Free cash flow | -4.64926M | -5.82960M | -4.78765M | -3.65501M | -1.39377M |
Sector: Technology Industry: Scientific & Technical Instruments
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AIMD Ainos Inc |
0.16 8.51% | 2.04 | - | 13.91 | 104.76 | 1.72 | 189.99 | -1.5997 |
| KYCCF Keyence |
-0.27 0.06% | 475.00 | 41.66 | 38.76 | 0.11 | 5.69 | 0.10 | 0.19 |
| COHR Coherent Inc |
-3.96 1.03% | 378.85 | 333.78 | 46.73 | 10.24 | 7.63 | 10.78 | 62.92 |
| GRMN Garmin Ltd |
-3.07 1.31% | 231.89 | 30.87 | 28.41 | 7.05 | 5.74 | 6.75 | 23.69 |
| HXGBY Hexagon AB ADR |
0.10 1.17% | 8.63 | 33.46 | 33.33 | 6.00 | 2.83 | 6.50 | 29.28 |
Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women's health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.
8880 Rio San Diego Drive, San Diego, CA, United States, 92108
| Name | Title | Year Born |
|---|---|---|
| Mr. Chun-Hsien Tsai | Chairman of Board, Pres & CEO | 1970 |
| Ms. Hui-Lan Wu | Chief Financial Officer | 1961 |
| Mr. Lawrence Kennedy Lin | Exec. VP of Operations | 1969 |
| Mr. John Junyong Lee Esq. | Chief Legal Counsel, Corp. Counsel & Sec. | 1967 |
| Mr. Chih-Heng Lu | Corp. Sec. of Board & Director of Corp. Devel. | 1980 |
| Mr. Chun-Hsien Tsai | Chairman of Board, President & CEO | 1970 |
| Mr. Lawrence Kennedy Lin | Executive Vice President of Operations | 1969 |
| Mr. Hsin-Liang Lee | Chief Financial Officer | 1971 |
| Mr. Chih-Heng Lu | Director of Corporate Developoment | 1980 |
| Mr. Chun-Hsien Tsai | CEO, President & Chairman of the Board | 1970 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.